HALO logo
halo search icon
Stoke Therapeutics, Inc.

US$29.67

Price Change Indicator
-0.625 (-2.063%)
Stoke Therapeutics, Inc.
STOK · NAS

Stoke Therapeutics, Inc.

Start Trading STOK for Free

US$29.67

Price Arrow-0.625 (-2.063%)
21/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusEMA 125 BreakdownExtreme OversoldHALO AllHammer BearishHammer Bearish (Realtime)Near Support
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Stoke Therapeutics, Inc. Overview

STOK Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Neutral

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Strong

About STOK

icon
icon

Telephone

1.781.430.8200

icon

Address

45 Wiggins Avenue, Bedford, MA 01730

Description

Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver. The company was founded by Isabel Aznarez and Adrian R. Krainer in June 2014 and is headquartered in Bedford, MA.

STOK Price Chart

Key Stats

Market Cap

US$1.89B

PE

NaN

EV/EBITDA

769

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 9.09 - 40.22

Trade Value (12mth)

US$5,689,792.00

1 week

0.71%

1 month

-15.61%

YTD

-1.96%

1 year

218.89%

All time high

71.58

Key Fundamentals

EPS 3 yr Growth

-95.50%

EBITDA Margin

-8.90%

Operating Cashflow

$46m

Free Cash Flow Return

15.60%

ROIC

-2.40%

Interest Coverage

NaN

Quick Ratio

5.30

Other Data

Shares Outstanding (Fully Diluted)

63m

HALO Sector

Healthcare

Next Company Report Date

16-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

STOK Announcements

Latest Announcements

DateAnnouncements
08 May 26
08 May 26
08 May 26
08 May 26
08 May 26

STOK Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-2.38-1.65-0.12locklocklock
EPS (Fully Diluted)
 $locklocklocklock-2.38-1.65-0.12locklocklock
Growth
 %locklocklocklock8.430.892.9locklocklock
PE
 XlocklocklocklockN/AN/A3,944.4locklocklock
EV/EBITDA
 XlocklocklocklockN/AN/A769locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Stoke Therapeutics, Inc. (STOK:NAS)?
Halo FAQ
The current share price of Stoke Therapeutics, Inc. (STOK:NAS) is USD$29.67.
What is the 52-week high share price for Stoke Therapeutics, Inc. (STOK:NAS)?
Halo FAQ
The 52-week high share price for Stoke Therapeutics, Inc. (STOK:NAS) is USD$40.22.
What is the 52-week low share price for Stoke Therapeutics, Inc. (STOK:NAS)?
Halo FAQ
The 52-week low share price for Stoke Therapeutics, Inc. (STOK:NAS) is USD$9.09.
What is the dividend yield for Stoke Therapeutics, Inc. (STOK:NAS)?
Halo FAQ
Stoke Therapeutics, Inc. (STOK:NAS) does not pay a dividend.
What was Stoke Therapeutics, Inc. (STOK:NAS) last dividend payment?
Halo FAQ
Stoke Therapeutics, Inc. (STOK:NAS) does not pay a dividend.
What is the franking level for Stoke Therapeutics, Inc. (STOK:NAS)?
Halo FAQ
Stoke Therapeutics, Inc. (STOK:NAS) has a franking level of 0.00%.
In which sector is Stoke Therapeutics, Inc. (STOK:NAS) classified?
Halo FAQ
Stoke Therapeutics, Inc. (STOK:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial